Posted Jun. 10, 2013 at 6:22 a.m.

Premium Lock Bioengineered blood vessels from RTP firm start clinical trials at Duke

Published: 2013-06-10 06:22:00
Updated: 2013-06-10 06:22:00

Bioengineered blood vessel A bioengineered blood vessel is implanted in a patient as part of Humacyte's clinical trial. Photo c/o Duke Medicine. Image 1 of 2 · Next Image…

A blood vessel grown in a lab was implanted in the first U.S. patient this week. Read more about Humacyte, the RTP firm that developed this regenerative medicine technology....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll